The first is misleading ads.
"He did so voluntarily," the agency said.
In addition to Bextra, Pfizer also makes Celebrex, the best-selling COX-2 drug on the market.
``That's the tragedy here.''
``I was stunned,'' said Kim who had expected positive results.
Yet Merck continued advertising.
(On Friday, Pfizer Inc. issued a warning that its Cox-2 drug Bextra may increase cardiovascular risk for some patients.)
``I thought the risk was going to be larger than it was,'' he said.
I couldn't see Merck saying we're going to market a drug with a safety problem.''
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
